Perriello and coworkers analyzed a large cohort of NPM1-mutated AML patients and confirmed that CD123 is highly expressed in these leukemias, particularly at the level of the CD34+/CD38− cell population [22]. The gene discussed is NPM1; the disease is acute myeloid leukemia.